Absence of seroprevalence against cytomegalovirus and herpes simplex in a group of patients with coronary atherosclerosis
López de Atalaya, J.; Cour, M.I.; García, M.C.; Ferro, A.; Perezagua, C.
Anales de Medicina Interna 6(1): 53
1989
ISSN/ISBN: 0212-7199 PMID: 2562342 Document Number: 327571
Document emailed within 1 workday
Related Documents
Sorlie, P.D.; Nieto, F.J.; Adam, E.; Folsom, A.R.; Shahar, E.; Massing, M. 2000: A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study Archives of Internal Medicine 160(13): 2027-2032Colette Smit, C.P.,A.M.,J.T.,J.S.,B.B.,R.C.andN.H.T.M.D. 2007: Rise in seroprevalence of herpes simplex virus type 1 among highly sexual active homosexual men and an increasing association between herpes simplex virus type 2 and Hiv over time (19842003) European Journal of Epidemiology 22(12): 937-944
Suligoi, B.; Torri, A.; Grilli, G.; Tanzi, E.; Palú, G. 2004: Seroprevalence and seroincidence of herpes simplex virus type 1 and herpes simplex virus type 2 infections in a cohort of adolescents in Italy Sexually Transmitted Diseases 31(10): 608-610
Agabi, Y.A.; Banwat, E.B.; Mawak, J.D.; Lar, P.M.; Dashe, N.; Dashen, M.M.; Adoga, M.P.; Agabi, F.Y.; Zakari, H. 2010: Seroprevalence of herpes simplex virus type-2 among patients attending the Sexually Transmitted Infections Clinic in Jos, Nigeria Journal of Infection in Developing Countries 4(9): 572-575
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Lilli, D.; Lorino, G.; Cipriani, P.; Berloco, P.; Pretagostini, R.; Mancini, C. 1987: Seroepidemiologic studies in 63 patients given organ transplants in relation to cytomegalovirus, herpes simplex, varicella-zoster and HTLV-III: validity and limits Bollettino dell'Istituto Sieroterapico Milanese 66(3): 198-201
Lewis, L.M.; Bernstein, D.I.; Rosenthal, S.L.; Stanberry, L.R. 1999: Seroprevalence of herpes simplex virus-type 2 in African-American college women Journal of the National Medical Association 91(4): 210-212
Hayes, K. 1978: Cytomegalovirus and herpes simplex virus: wolves in sheep's clothing Australian Family Physician 7(5): 552-568
Chawla, R.; Bhalla, P.; Bhalla, K.; Singh, M.M.; Garg, S. 2008: Community-based study on seroprevalence of herpes simplex virus type 2 infection in new Delhi Indian Journal of Medical Microbiology 26(1): 34-39
Conde-González, C.J.; Lazcano-Ponce, E.; Hernández-Girón, C.; Juárez-Figueroa, L.; Smith, J.S.; Hernández-Avila, M. 2003: Seroprevalence of type 2 herpes simplex virus infection in 3 population groups of Mexico City Salud Publica de Mexico 45 Supp 5: S608-S616
Suárez, M.; Briones, H.; Alarcón, G.; Aliaga, P.; Grunberg, A.; de Diego, S.; del Solar, E. 1992: Herpes simplex virus and cytomegalovirus in pregnant Chilean university students Bulletin of the Pan American Health Organization 26(3): 242-246
Sanchez-Aleman, M.Angel.; Del Villar-Tapia, Y.Georgina.; Gutierrez, J.Pablo.; Garcia-Cisneros, S.; Olamendi-Portugal, M.Leonidez.; Herrera-Ortiz, A.; Velazquez-Meza, M.; Conde-Glez, C.J. 2018: Heterogeneity of Herpes Simplex Virus Type 2 Seroprevalence From a National Probability Survey In Mexico, 2012 Sexually Transmitted Diseases 45(2): 111-117
Hayward, A.R.; Herberger, M.J.; Groothuis, J.; Levin, M.R. 1984: Specific immunity after congenital or neonatal infection with cytomegalovirus or herpes simplex virus Journal of Immunology 133(5): 2469-2473
Biswas, D.; Borkakoty, B.; Mahanta, J.; Walia, K.; Saikia, L.; Akoijam, B.S.; Jampa, L.; Kharkongar, A.; Zomawia, E. 2011: Seroprevalence and risk factors of herpes simplex virus type-2 infection among pregnant women in Northeast India Bmc Infectious Diseases 11: 325
Bos, P.; Steele, D.; Alexander, J. 1995: Prevalence of antibodies to rubella, herpes simplex 2 and cytomegalovirus in pregnant women and in neonates at Ga-Rankuwa Central African Journal of Medicine 41(1): 14-17
Rudneva, I.A.; Germanov, A.B.; Miasnikova, I.A.; Sokolov, M.I. 1970: Genetic markers of herpes simplex virus. 2. Study of genetic markers of the US strain of herpes simplex virus of the 3d antigenic group Voprosy Virusologii 15(2): 182-186
Barinskiĭ, I.F.; Bakaev, V.V.; Posevaia, T.A.; Klincheva, S.A.; Nikolaeva, N.P.; Dlinn, V.V.; Shebalina, N.V. 1994: Selection of primers and their use in the polymerase chain reaction for diagnosing infections caused by herpes simplex virus and cytomegalovirus Voprosy Virusologii 39(6): 245-247
Szántó, J.; Lesso, J.; Lackovic, V. 1976: Persistent infection of BHK cells with herpes simplex virus types 1 and 2 in the absence of specific anti-herpetic antibody Acta Virologica 20(1): 40-47
Sudfeld, C.R.; Hewett, P.C.; Abuelezam, N.N.; Chalasani, S.; Soler-Hampejsek, E.; Kelly, C.A.; Mensch, B.S. 2013: Herpes simplex virus type 2 cross-sectional seroprevalence and the estimated rate of neonatal infections among a cohort of rural Malawian female adolescents Sexually Transmitted Infections 89(7): 561-567